Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant non » significant gap (Expand Search), significant amount (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant non » significant gap (Expand Search), significant amount (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
-
861
-
862
-
863
Loxoprofen or SB225002 administration attenuated inflammatory pain in complete Freund’s adjuvant (CFA)-injected mice exposed to sound stress.
Published 2025“…<b>(B)</b> SB225002 administration (3 mg/kg) significantly decreased the response times to filament in CFA + stress + saline group (60 min, <i>P</i> = 0.0037). …”
-
864
-
865
-
866
-
867
-
868
-
869
-
870
-
871
-
872
Changes in bioimpedance by sex.
Published 2025“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. …”
-
873
Clinical and epidemiological characteristics.
Published 2025“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. …”
-
874
Changes in bioimpedance by age.
Published 2025“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. …”
-
875
S1 Data -
Published 2025“…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. …”
-
876
-
877
-
878
Flowchart of the study population.
Published 2025“…Identified early-onset FGR had a decreased risk of stillbirth (aOR 0.47, 95% CI 0.23–0.96), an increased risk of severe newborn distress (aOR 2.80, 95% CI 1.79–4.39) and severe childhood outcome (aOR 3.00, 95% CI 1.51–5.94), compared to non-identified SGA/FGR. …”
-
879
-
880